XML 60 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Jun. 24, 2012
Jun. 26, 2011
Jun. 27, 2010
Cash flow from operating activities:      
Net income (loss) $ (55,050) $ 166,546 $ 80,827
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization 84,951 77,137 70,686
Amortization of acquisition-related intangible assets 8,369 6,768 4,375
(Gain) loss on disposal of fixed assets 1,695 (250) 559
Gain on disposition of property (5,410) 0 0
Stock compensation expense 16,141 15,614 11,419
Impairment of goodwill 69,421 0 0
Gain on sale of investments (55) (7,985) (6,485)
Other-than-temporary impairment of investments 2,865 1,433 3,349
Provision for (recovery of) bad debts 1,015 (2,117) (2,168)
Provision for (recovery of) inventory write-downs 18,734 9,129 (2,997)
Impairment of assets 2,530    
Loss (gain) on derivatives (1,079) 3,872 (3,427)
Deferred income taxes (25,183) (19,693) (5,885)
Tax benefit from stock-based awards 1,674 1,406 0
Excess tax benefit from stock-based awards (864) (3,400) (197)
Changes in operating assets and liabilities, net (83,461) (80,735) (100,734)
Other 4,758 (5,836) 3,689
Net cash provided by operating activities 41,051 161,889 53,011
Cash flow from investing activities:      
Additions to property, plant and equipment (128,083) (146,345) (58,071)
Proceeds from sale of property, plant and equipment 5,524 800 535
Business acquisitions 0 (75,668) 0
Acquisitions of intellectual property 0 (7,500) 0
Withdrawals from deferred compensation plan 0 0 2,443
Sale of investments 75,792 128,210 146,667
Maturities of investments 216,307 331,594 146,060
Purchase of investments (173,383) (305,481) (407,399)
Redemption of equity investment 0 0 2,050
Released from restricted cash 524 1,595 259
Purchase of cost-based investments 0 (1,850) 0
Net cash used in investing activities (3,319) (74,645) (167,456)
Cash flow from financing activities:      
Proceeds from exercise of stock options 3,269 11,412 5,629
Excess tax benefit from stock-based awards 864 3,400 197
Purchase of treasury stock (26,720) (32,574) (25,039)
Net settlement of restricted stock units for tax withholdings (4,260) (3,551) (782)
Net cash used in financing activities (26,847) (21,313) (19,995)
Effect of exchange rate changes on cash and cash equivalents (4,193) 3,011 (1,532)
Net increase (decrease) in cash and cash equivalents 6,692 68,942 (135,972)
Cash and cash equivalents, beginning of year 298,731 229,789 365,761
Cash and cash equivalents, end of year $ 305,423 $ 298,731 $ 229,789